Biocept Inc (NQ: BIOC )

6.330 USD -0.220 (-3.36%)

Official Closing Price Updated: 5:17 PM EST, Jan 26, 2021 Add to My Watchlist

Price and Volume

Volume	448,496
Open	6.590
Bid (Size)	6.210 (5)
Ask (Size)	6.250 (10)
Prev. Close	6.550
Today's Range	6.250 - 6.610
52wk Range	0.2100 - 6.780
Shares Outstanding	68,213,349
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Biocept to Present at H.C. Wainwright Virtual BioConnect Conference

January 04, 2021

CEO Michael Nall to participate in diagnostics and devices panel discussion hosted by former FDA Commissioner Dr. Scott Gottlieb

Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 31, 2020

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve...

Performance

YTD	+33.54%	+33.54%
1 Month	+31.33%	+31.33%
3 Month	+45.18%	+45.18%
6 Month	+805.32%	+805.32%
1 Year	+1941.94%	+1941.94%

More News

Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations

December 30, 2020

Biocept Provides Business Update

December 14, 2020

Biocept Issues Letter to Stockholders

January 12, 2021

Biocept's Target Selector™ Liquid Biopsy Demonstrated High Accuracy When Used for Monitoring the Progression of Metastatic Breast Cancer in Study Conducted at Johns Hopkins Sidney Kimmel Cancer Center

December 10, 2020

While The U.S. Faces Insufficient COVID-19 Testing Volume, EIR Healthcare Launches MedModLabs to Expand Access Immediately

December 01, 2020

Study Shows Biocept's Assays are Viable and Sensitive for Detecting Tumor Cells and Biomarkers in the Cerebrospinal Fluid of Patients with Breast and Lung Cancer that has Metastasized to the Central N

November 20, 2020

Results from Study Using Biocept's Target Selector™ Testing to Monitor Breast Cancer Disease Progression to be Presented at 2020 SABCS®

November 17, 2020

Biocept Reports Third Quarter 2020 Financial Results

November 12, 2020

12 Healthcare Stocks Moving In Friday's Intraday Session

November 13, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.